nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—PTGS1—Ifosfamide—testicular cancer	0.162	0.26	CbGbCtD
Zopiclone—CYP2C8—Ifosfamide—testicular cancer	0.0936	0.15	CbGbCtD
Zopiclone—PTGS1—Etoposide—testicular cancer	0.0775	0.124	CbGbCtD
Zopiclone—CYP2C9—Ifosfamide—testicular cancer	0.0653	0.105	CbGbCtD
Zopiclone—CYP2E1—Etoposide—testicular cancer	0.0599	0.096	CbGbCtD
Zopiclone—CYP2C8—Etoposide—testicular cancer	0.0447	0.0717	CbGbCtD
Zopiclone—CYP3A4—Ifosfamide—testicular cancer	0.038	0.0609	CbGbCtD
Zopiclone—CYP2C9—Cisplatin—testicular cancer	0.0318	0.0509	CbGbCtD
Zopiclone—CYP3A4—Vinblastine—testicular cancer	0.0201	0.0323	CbGbCtD
Zopiclone—CYP3A4—Etoposide—testicular cancer	0.0181	0.0291	CbGbCtD
Zopiclone—CYP3A4—Doxorubicin—testicular cancer	0.0124	0.0198	CbGbCtD
Zopiclone—Pain—Cisplatin—testicular cancer	0.00032	0.00085	CcSEcCtD
Zopiclone—Dermatitis—Bleomycin—testicular cancer	0.00032	0.00085	CcSEcCtD
Zopiclone—Hypersensitivity—Ifosfamide—testicular cancer	0.00032	0.00085	CcSEcCtD
Zopiclone—Muscular weakness—Doxorubicin—testicular cancer	0.000319	0.000848	CcSEcCtD
Zopiclone—Dysuria—Epirubicin—testicular cancer	0.000316	0.00084	CcSEcCtD
Zopiclone—Stomatitis—Methotrexate—testicular cancer	0.000314	0.000834	CcSEcCtD
Zopiclone—Conjunctivitis—Methotrexate—testicular cancer	0.000313	0.000832	CcSEcCtD
Zopiclone—Dysphagia—Doxorubicin—testicular cancer	0.000313	0.000831	CcSEcCtD
Zopiclone—Asthma—Doxorubicin—testicular cancer	0.000313	0.000831	CcSEcCtD
Zopiclone—Influenza—Doxorubicin—testicular cancer	0.000313	0.000831	CcSEcCtD
Zopiclone—Pollakiuria—Epirubicin—testicular cancer	0.000312	0.00083	CcSEcCtD
Zopiclone—Asthenia—Ifosfamide—testicular cancer	0.000312	0.000828	CcSEcCtD
Zopiclone—Sweating—Methotrexate—testicular cancer	0.000309	0.00082	CcSEcCtD
Zopiclone—Photosensitivity reaction—Epirubicin—testicular cancer	0.000309	0.00082	CcSEcCtD
Zopiclone—Feeling abnormal—Cisplatin—testicular cancer	0.000309	0.00082	CcSEcCtD
Zopiclone—Paraesthesia—Etoposide—testicular cancer	0.000308	0.000818	CcSEcCtD
Zopiclone—Weight increased—Epirubicin—testicular cancer	0.000308	0.000817	CcSEcCtD
Zopiclone—Pruritus—Ifosfamide—testicular cancer	0.000307	0.000816	CcSEcCtD
Zopiclone—Haematuria—Methotrexate—testicular cancer	0.000307	0.000816	CcSEcCtD
Zopiclone—Weight decreased—Epirubicin—testicular cancer	0.000306	0.000813	CcSEcCtD
Zopiclone—Dyspnoea—Etoposide—testicular cancer	0.000306	0.000812	CcSEcCtD
Zopiclone—Somnolence—Etoposide—testicular cancer	0.000305	0.00081	CcSEcCtD
Zopiclone—Epistaxis—Methotrexate—testicular cancer	0.000304	0.000807	CcSEcCtD
Zopiclone—Nausea—Bleomycin—testicular cancer	0.000302	0.000802	CcSEcCtD
Zopiclone—Drowsiness—Epirubicin—testicular cancer	0.000301	0.000801	CcSEcCtD
Zopiclone—Vomiting—Dactinomycin—testicular cancer	0.000301	0.0008	CcSEcCtD
Zopiclone—Bronchitis—Doxorubicin—testicular cancer	0.000301	0.000799	CcSEcCtD
Zopiclone—Rash—Dactinomycin—testicular cancer	0.000299	0.000794	CcSEcCtD
Zopiclone—Decreased appetite—Etoposide—testicular cancer	0.000298	0.000792	CcSEcCtD
Zopiclone—Diarrhoea—Ifosfamide—testicular cancer	0.000297	0.000789	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Etoposide—testicular cancer	0.000296	0.000787	CcSEcCtD
Zopiclone—Body temperature increased—Cisplatin—testicular cancer	0.000296	0.000786	CcSEcCtD
Zopiclone—Fatigue—Etoposide—testicular cancer	0.000296	0.000786	CcSEcCtD
Zopiclone—Neuropathy peripheral—Epirubicin—testicular cancer	0.000296	0.000785	CcSEcCtD
Zopiclone—Stomatitis—Epirubicin—testicular cancer	0.000294	0.000781	CcSEcCtD
Zopiclone—Constipation—Etoposide—testicular cancer	0.000293	0.000779	CcSEcCtD
Zopiclone—Pain—Etoposide—testicular cancer	0.000293	0.000779	CcSEcCtD
Zopiclone—Conjunctivitis—Epirubicin—testicular cancer	0.000293	0.000778	CcSEcCtD
Zopiclone—Urinary tract infection—Epirubicin—testicular cancer	0.000293	0.000778	CcSEcCtD
Zopiclone—Dysuria—Doxorubicin—testicular cancer	0.000293	0.000777	CcSEcCtD
Zopiclone—Hepatitis—Methotrexate—testicular cancer	0.000289	0.000768	CcSEcCtD
Zopiclone—Sweating—Epirubicin—testicular cancer	0.000289	0.000768	CcSEcCtD
Zopiclone—Pollakiuria—Doxorubicin—testicular cancer	0.000289	0.000768	CcSEcCtD
Zopiclone—Haematuria—Epirubicin—testicular cancer	0.000287	0.000764	CcSEcCtD
Zopiclone—Dizziness—Ifosfamide—testicular cancer	0.000287	0.000763	CcSEcCtD
Zopiclone—Pharyngitis—Methotrexate—testicular cancer	0.000287	0.000762	CcSEcCtD
Zopiclone—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000286	0.000759	CcSEcCtD
Zopiclone—Weight increased—Doxorubicin—testicular cancer	0.000285	0.000756	CcSEcCtD
Zopiclone—Epistaxis—Epirubicin—testicular cancer	0.000284	0.000755	CcSEcCtD
Zopiclone—Weight decreased—Doxorubicin—testicular cancer	0.000283	0.000752	CcSEcCtD
Zopiclone—Feeling abnormal—Etoposide—testicular cancer	0.000283	0.000751	CcSEcCtD
Zopiclone—Nausea—Dactinomycin—testicular cancer	0.000282	0.000748	CcSEcCtD
Zopiclone—Gastrointestinal pain—Etoposide—testicular cancer	0.00028	0.000745	CcSEcCtD
Zopiclone—Drowsiness—Doxorubicin—testicular cancer	0.000279	0.000741	CcSEcCtD
Zopiclone—Vomiting—Ifosfamide—testicular cancer	0.000276	0.000733	CcSEcCtD
Zopiclone—Hypersensitivity—Cisplatin—testicular cancer	0.000276	0.000733	CcSEcCtD
Zopiclone—Rash—Ifosfamide—testicular cancer	0.000274	0.000727	CcSEcCtD
Zopiclone—Dermatitis—Ifosfamide—testicular cancer	0.000274	0.000727	CcSEcCtD
Zopiclone—Erythema multiforme—Methotrexate—testicular cancer	0.000273	0.000726	CcSEcCtD
Zopiclone—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000273	0.000726	CcSEcCtD
Zopiclone—Urticaria—Etoposide—testicular cancer	0.000273	0.000724	CcSEcCtD
Zopiclone—Stomatitis—Doxorubicin—testicular cancer	0.000272	0.000722	CcSEcCtD
Zopiclone—Rhinitis—Epirubicin—testicular cancer	0.000271	0.000721	CcSEcCtD
Zopiclone—Abdominal pain—Etoposide—testicular cancer	0.000271	0.00072	CcSEcCtD
Zopiclone—Body temperature increased—Etoposide—testicular cancer	0.000271	0.00072	CcSEcCtD
Zopiclone—Conjunctivitis—Doxorubicin—testicular cancer	0.000271	0.00072	CcSEcCtD
Zopiclone—Urinary tract infection—Doxorubicin—testicular cancer	0.000271	0.00072	CcSEcCtD
Zopiclone—Hepatitis—Epirubicin—testicular cancer	0.000271	0.000719	CcSEcCtD
Zopiclone—Tinnitus—Methotrexate—testicular cancer	0.00027	0.000716	CcSEcCtD
Zopiclone—Hypoaesthesia—Epirubicin—testicular cancer	0.000269	0.000715	CcSEcCtD
Zopiclone—Asthenia—Cisplatin—testicular cancer	0.000269	0.000714	CcSEcCtD
Zopiclone—Pharyngitis—Epirubicin—testicular cancer	0.000269	0.000713	CcSEcCtD
Zopiclone—Sweating—Doxorubicin—testicular cancer	0.000267	0.00071	CcSEcCtD
Zopiclone—Oedema peripheral—Epirubicin—testicular cancer	0.000267	0.000708	CcSEcCtD
Zopiclone—Haematuria—Doxorubicin—testicular cancer	0.000266	0.000706	CcSEcCtD
Zopiclone—Epistaxis—Doxorubicin—testicular cancer	0.000263	0.000699	CcSEcCtD
Zopiclone—Chills—Methotrexate—testicular cancer	0.000259	0.000689	CcSEcCtD
Zopiclone—Nausea—Ifosfamide—testicular cancer	0.000258	0.000685	CcSEcCtD
Zopiclone—Diarrhoea—Cisplatin—testicular cancer	0.000256	0.00068	CcSEcCtD
Zopiclone—Erythema multiforme—Epirubicin—testicular cancer	0.000256	0.00068	CcSEcCtD
Zopiclone—Alopecia—Methotrexate—testicular cancer	0.000256	0.000679	CcSEcCtD
Zopiclone—Hypersensitivity—Etoposide—testicular cancer	0.000253	0.000671	CcSEcCtD
Zopiclone—Tinnitus—Epirubicin—testicular cancer	0.000252	0.00067	CcSEcCtD
Zopiclone—Rhinitis—Doxorubicin—testicular cancer	0.000251	0.000667	CcSEcCtD
Zopiclone—Hepatitis—Doxorubicin—testicular cancer	0.00025	0.000665	CcSEcCtD
Zopiclone—Hypoaesthesia—Doxorubicin—testicular cancer	0.000249	0.000662	CcSEcCtD
Zopiclone—Pharyngitis—Doxorubicin—testicular cancer	0.000249	0.00066	CcSEcCtD
Zopiclone—Oedema peripheral—Doxorubicin—testicular cancer	0.000247	0.000655	CcSEcCtD
Zopiclone—Dysgeusia—Methotrexate—testicular cancer	0.000247	0.000655	CcSEcCtD
Zopiclone—Asthenia—Etoposide—testicular cancer	0.000246	0.000654	CcSEcCtD
Zopiclone—Back pain—Methotrexate—testicular cancer	0.000244	0.000647	CcSEcCtD
Zopiclone—Chills—Epirubicin—testicular cancer	0.000243	0.000645	CcSEcCtD
Zopiclone—Pruritus—Etoposide—testicular cancer	0.000243	0.000645	CcSEcCtD
Zopiclone—Alopecia—Epirubicin—testicular cancer	0.000239	0.000635	CcSEcCtD
Zopiclone—Vomiting—Cisplatin—testicular cancer	0.000238	0.000632	CcSEcCtD
Zopiclone—Vision blurred—Methotrexate—testicular cancer	0.000237	0.00063	CcSEcCtD
Zopiclone—Erythema multiforme—Doxorubicin—testicular cancer	0.000237	0.000629	CcSEcCtD
Zopiclone—Rash—Cisplatin—testicular cancer	0.000236	0.000627	CcSEcCtD
Zopiclone—Dermatitis—Cisplatin—testicular cancer	0.000236	0.000626	CcSEcCtD
Zopiclone—Diarrhoea—Etoposide—testicular cancer	0.000235	0.000623	CcSEcCtD
Zopiclone—Ill-defined disorder—Methotrexate—testicular cancer	0.000234	0.00062	CcSEcCtD
Zopiclone—Tinnitus—Doxorubicin—testicular cancer	0.000233	0.00062	CcSEcCtD
Zopiclone—Anaemia—Methotrexate—testicular cancer	0.000233	0.000618	CcSEcCtD
Zopiclone—Tension—Epirubicin—testicular cancer	0.000231	0.000614	CcSEcCtD
Zopiclone—Dysgeusia—Epirubicin—testicular cancer	0.000231	0.000613	CcSEcCtD
Zopiclone—Nervousness—Epirubicin—testicular cancer	0.000229	0.000608	CcSEcCtD
Zopiclone—Back pain—Epirubicin—testicular cancer	0.000228	0.000605	CcSEcCtD
Zopiclone—Malaise—Methotrexate—testicular cancer	0.000227	0.000603	CcSEcCtD
Zopiclone—Dizziness—Etoposide—testicular cancer	0.000227	0.000603	CcSEcCtD
Zopiclone—Muscle spasms—Epirubicin—testicular cancer	0.000227	0.000602	CcSEcCtD
Zopiclone—Vertigo—Methotrexate—testicular cancer	0.000226	0.000601	CcSEcCtD
Zopiclone—Chills—Doxorubicin—testicular cancer	0.000225	0.000597	CcSEcCtD
Zopiclone—Nausea—Cisplatin—testicular cancer	0.000222	0.000591	CcSEcCtD
Zopiclone—Vision blurred—Epirubicin—testicular cancer	0.000222	0.00059	CcSEcCtD
Zopiclone—Alopecia—Doxorubicin—testicular cancer	0.000221	0.000588	CcSEcCtD
Zopiclone—Ill-defined disorder—Epirubicin—testicular cancer	0.000219	0.000581	CcSEcCtD
Zopiclone—Convulsion—Methotrexate—testicular cancer	0.000218	0.000579	CcSEcCtD
Zopiclone—Vomiting—Etoposide—testicular cancer	0.000218	0.000579	CcSEcCtD
Zopiclone—Anaemia—Epirubicin—testicular cancer	0.000218	0.000578	CcSEcCtD
Zopiclone—Agitation—Epirubicin—testicular cancer	0.000217	0.000575	CcSEcCtD
Zopiclone—Rash—Etoposide—testicular cancer	0.000216	0.000574	CcSEcCtD
Zopiclone—Dermatitis—Etoposide—testicular cancer	0.000216	0.000574	CcSEcCtD
Zopiclone—Headache—Etoposide—testicular cancer	0.000215	0.000571	CcSEcCtD
Zopiclone—Chest pain—Methotrexate—testicular cancer	0.000214	0.000569	CcSEcCtD
Zopiclone—Myalgia—Methotrexate—testicular cancer	0.000214	0.000569	CcSEcCtD
Zopiclone—Tension—Doxorubicin—testicular cancer	0.000214	0.000568	CcSEcCtD
Zopiclone—Dysgeusia—Doxorubicin—testicular cancer	0.000213	0.000567	CcSEcCtD
Zopiclone—Malaise—Epirubicin—testicular cancer	0.000212	0.000564	CcSEcCtD
Zopiclone—Discomfort—Methotrexate—testicular cancer	0.000212	0.000562	CcSEcCtD
Zopiclone—Nervousness—Doxorubicin—testicular cancer	0.000212	0.000562	CcSEcCtD
Zopiclone—Vertigo—Epirubicin—testicular cancer	0.000212	0.000562	CcSEcCtD
Zopiclone—Back pain—Doxorubicin—testicular cancer	0.000211	0.00056	CcSEcCtD
Zopiclone—Muscle spasms—Doxorubicin—testicular cancer	0.00021	0.000557	CcSEcCtD
Zopiclone—Palpitations—Epirubicin—testicular cancer	0.000208	0.000553	CcSEcCtD
Zopiclone—Confusional state—Methotrexate—testicular cancer	0.000207	0.00055	CcSEcCtD
Zopiclone—Anaphylactic shock—Methotrexate—testicular cancer	0.000205	0.000546	CcSEcCtD
Zopiclone—Vision blurred—Doxorubicin—testicular cancer	0.000205	0.000546	CcSEcCtD
Zopiclone—Convulsion—Epirubicin—testicular cancer	0.000204	0.000542	CcSEcCtD
Zopiclone—Infection—Methotrexate—testicular cancer	0.000204	0.000542	CcSEcCtD
Zopiclone—Nausea—Etoposide—testicular cancer	0.000204	0.000541	CcSEcCtD
Zopiclone—Hypertension—Epirubicin—testicular cancer	0.000203	0.00054	CcSEcCtD
Zopiclone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000202	0.000537	CcSEcCtD
Zopiclone—Anaemia—Doxorubicin—testicular cancer	0.000201	0.000535	CcSEcCtD
Zopiclone—Chest pain—Epirubicin—testicular cancer	0.000201	0.000533	CcSEcCtD
Zopiclone—Myalgia—Epirubicin—testicular cancer	0.000201	0.000533	CcSEcCtD
Zopiclone—Agitation—Doxorubicin—testicular cancer	0.0002	0.000532	CcSEcCtD
Zopiclone—Anxiety—Epirubicin—testicular cancer	0.0002	0.000531	CcSEcCtD
Zopiclone—Hyperhidrosis—Methotrexate—testicular cancer	0.000199	0.000528	CcSEcCtD
Zopiclone—Discomfort—Epirubicin—testicular cancer	0.000198	0.000526	CcSEcCtD
Zopiclone—Malaise—Doxorubicin—testicular cancer	0.000197	0.000522	CcSEcCtD
Zopiclone—Dry mouth—Epirubicin—testicular cancer	0.000196	0.000521	CcSEcCtD
Zopiclone—Vertigo—Doxorubicin—testicular cancer	0.000196	0.00052	CcSEcCtD
Zopiclone—Anorexia—Methotrexate—testicular cancer	0.000196	0.00052	CcSEcCtD
Zopiclone—Confusional state—Epirubicin—testicular cancer	0.000194	0.000515	CcSEcCtD
Zopiclone—Palpitations—Doxorubicin—testicular cancer	0.000193	0.000512	CcSEcCtD
Zopiclone—Anaphylactic shock—Epirubicin—testicular cancer	0.000192	0.000511	CcSEcCtD
Zopiclone—Infection—Epirubicin—testicular cancer	0.000191	0.000507	CcSEcCtD
Zopiclone—Convulsion—Doxorubicin—testicular cancer	0.000189	0.000502	CcSEcCtD
Zopiclone—Hypertension—Doxorubicin—testicular cancer	0.000188	0.0005	CcSEcCtD
Zopiclone—Tachycardia—Epirubicin—testicular cancer	0.000188	0.000498	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000187	0.000497	CcSEcCtD
Zopiclone—Hyperhidrosis—Epirubicin—testicular cancer	0.000186	0.000494	CcSEcCtD
Zopiclone—Insomnia—Methotrexate—testicular cancer	0.000186	0.000494	CcSEcCtD
Zopiclone—Chest pain—Doxorubicin—testicular cancer	0.000186	0.000493	CcSEcCtD
Zopiclone—Myalgia—Doxorubicin—testicular cancer	0.000186	0.000493	CcSEcCtD
Zopiclone—Anxiety—Doxorubicin—testicular cancer	0.000185	0.000491	CcSEcCtD
Zopiclone—Paraesthesia—Methotrexate—testicular cancer	0.000184	0.00049	CcSEcCtD
Zopiclone—Discomfort—Doxorubicin—testicular cancer	0.000183	0.000487	CcSEcCtD
Zopiclone—Anorexia—Epirubicin—testicular cancer	0.000183	0.000487	CcSEcCtD
Zopiclone—Dyspnoea—Methotrexate—testicular cancer	0.000183	0.000487	CcSEcCtD
Zopiclone—Somnolence—Methotrexate—testicular cancer	0.000183	0.000485	CcSEcCtD
Zopiclone—Dry mouth—Doxorubicin—testicular cancer	0.000182	0.000482	CcSEcCtD
Zopiclone—Dyspepsia—Methotrexate—testicular cancer	0.000181	0.00048	CcSEcCtD
Zopiclone—Confusional state—Doxorubicin—testicular cancer	0.000179	0.000476	CcSEcCtD
Zopiclone—Decreased appetite—Methotrexate—testicular cancer	0.000179	0.000474	CcSEcCtD
Zopiclone—Anaphylactic shock—Doxorubicin—testicular cancer	0.000178	0.000473	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000177	0.000471	CcSEcCtD
Zopiclone—Fatigue—Methotrexate—testicular cancer	0.000177	0.000471	CcSEcCtD
Zopiclone—Infection—Doxorubicin—testicular cancer	0.000177	0.000469	CcSEcCtD
Zopiclone—Pain—Methotrexate—testicular cancer	0.000176	0.000467	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000175	0.000465	CcSEcCtD
Zopiclone—Insomnia—Epirubicin—testicular cancer	0.000174	0.000462	CcSEcCtD
Zopiclone—Tachycardia—Doxorubicin—testicular cancer	0.000174	0.000461	CcSEcCtD
Zopiclone—Paraesthesia—Epirubicin—testicular cancer	0.000173	0.000459	CcSEcCtD
Zopiclone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000172	0.000457	CcSEcCtD
Zopiclone—Dyspnoea—Epirubicin—testicular cancer	0.000171	0.000455	CcSEcCtD
Zopiclone—Somnolence—Epirubicin—testicular cancer	0.000171	0.000454	CcSEcCtD
Zopiclone—Anorexia—Doxorubicin—testicular cancer	0.00017	0.00045	CcSEcCtD
Zopiclone—Feeling abnormal—Methotrexate—testicular cancer	0.000169	0.00045	CcSEcCtD
Zopiclone—Dyspepsia—Epirubicin—testicular cancer	0.000169	0.00045	CcSEcCtD
Zopiclone—Gastrointestinal pain—Methotrexate—testicular cancer	0.000168	0.000446	CcSEcCtD
Zopiclone—Decreased appetite—Epirubicin—testicular cancer	0.000167	0.000444	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000166	0.000441	CcSEcCtD
Zopiclone—Fatigue—Epirubicin—testicular cancer	0.000166	0.00044	CcSEcCtD
Zopiclone—Constipation—Epirubicin—testicular cancer	0.000164	0.000437	CcSEcCtD
Zopiclone—Pain—Epirubicin—testicular cancer	0.000164	0.000437	CcSEcCtD
Zopiclone—Urticaria—Methotrexate—testicular cancer	0.000163	0.000434	CcSEcCtD
Zopiclone—Body temperature increased—Methotrexate—testicular cancer	0.000162	0.000431	CcSEcCtD
Zopiclone—Abdominal pain—Methotrexate—testicular cancer	0.000162	0.000431	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000162	0.000431	CcSEcCtD
Zopiclone—Insomnia—Doxorubicin—testicular cancer	0.000161	0.000427	CcSEcCtD
Zopiclone—Paraesthesia—Doxorubicin—testicular cancer	0.00016	0.000424	CcSEcCtD
Zopiclone—Dyspnoea—Doxorubicin—testicular cancer	0.000159	0.000421	CcSEcCtD
Zopiclone—Feeling abnormal—Epirubicin—testicular cancer	0.000158	0.000421	CcSEcCtD
Zopiclone—Somnolence—Doxorubicin—testicular cancer	0.000158	0.00042	CcSEcCtD
Zopiclone—Gastrointestinal pain—Epirubicin—testicular cancer	0.000157	0.000418	CcSEcCtD
Zopiclone—Dyspepsia—Doxorubicin—testicular cancer	0.000157	0.000416	CcSEcCtD
Zopiclone—Decreased appetite—Doxorubicin—testicular cancer	0.000155	0.000411	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000154	0.000408	CcSEcCtD
Zopiclone—Fatigue—Doxorubicin—testicular cancer	0.000153	0.000407	CcSEcCtD
Zopiclone—Urticaria—Epirubicin—testicular cancer	0.000153	0.000406	CcSEcCtD
Zopiclone—Pain—Doxorubicin—testicular cancer	0.000152	0.000404	CcSEcCtD
Zopiclone—Constipation—Doxorubicin—testicular cancer	0.000152	0.000404	CcSEcCtD
Zopiclone—Body temperature increased—Epirubicin—testicular cancer	0.000152	0.000404	CcSEcCtD
Zopiclone—Abdominal pain—Epirubicin—testicular cancer	0.000152	0.000404	CcSEcCtD
Zopiclone—Hypersensitivity—Methotrexate—testicular cancer	0.000151	0.000402	CcSEcCtD
Zopiclone—Asthenia—Methotrexate—testicular cancer	0.000147	0.000392	CcSEcCtD
Zopiclone—Feeling abnormal—Doxorubicin—testicular cancer	0.000147	0.000389	CcSEcCtD
Zopiclone—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000145	0.000386	CcSEcCtD
Zopiclone—Pruritus—Methotrexate—testicular cancer	0.000145	0.000386	CcSEcCtD
Zopiclone—Hypersensitivity—Epirubicin—testicular cancer	0.000142	0.000376	CcSEcCtD
Zopiclone—Urticaria—Doxorubicin—testicular cancer	0.000141	0.000375	CcSEcCtD
Zopiclone—Abdominal pain—Doxorubicin—testicular cancer	0.000141	0.000374	CcSEcCtD
Zopiclone—Body temperature increased—Doxorubicin—testicular cancer	0.000141	0.000374	CcSEcCtD
Zopiclone—Diarrhoea—Methotrexate—testicular cancer	0.000141	0.000373	CcSEcCtD
Zopiclone—Asthenia—Epirubicin—testicular cancer	0.000138	0.000366	CcSEcCtD
Zopiclone—Pruritus—Epirubicin—testicular cancer	0.000136	0.000361	CcSEcCtD
Zopiclone—Dizziness—Methotrexate—testicular cancer	0.000136	0.000361	CcSEcCtD
Zopiclone—Diarrhoea—Epirubicin—testicular cancer	0.000132	0.000349	CcSEcCtD
Zopiclone—Hypersensitivity—Doxorubicin—testicular cancer	0.000131	0.000348	CcSEcCtD
Zopiclone—Vomiting—Methotrexate—testicular cancer	0.000131	0.000347	CcSEcCtD
Zopiclone—Rash—Methotrexate—testicular cancer	0.00013	0.000344	CcSEcCtD
Zopiclone—Dermatitis—Methotrexate—testicular cancer	0.000129	0.000344	CcSEcCtD
Zopiclone—Headache—Methotrexate—testicular cancer	0.000129	0.000342	CcSEcCtD
Zopiclone—Asthenia—Doxorubicin—testicular cancer	0.000128	0.000339	CcSEcCtD
Zopiclone—Dizziness—Epirubicin—testicular cancer	0.000127	0.000338	CcSEcCtD
Zopiclone—Pruritus—Doxorubicin—testicular cancer	0.000126	0.000334	CcSEcCtD
Zopiclone—Vomiting—Epirubicin—testicular cancer	0.000122	0.000325	CcSEcCtD
Zopiclone—Nausea—Methotrexate—testicular cancer	0.000122	0.000324	CcSEcCtD
Zopiclone—Diarrhoea—Doxorubicin—testicular cancer	0.000122	0.000323	CcSEcCtD
Zopiclone—Rash—Epirubicin—testicular cancer	0.000121	0.000322	CcSEcCtD
Zopiclone—Dermatitis—Epirubicin—testicular cancer	0.000121	0.000322	CcSEcCtD
Zopiclone—Headache—Epirubicin—testicular cancer	0.00012	0.00032	CcSEcCtD
Zopiclone—Dizziness—Doxorubicin—testicular cancer	0.000118	0.000313	CcSEcCtD
Zopiclone—Nausea—Epirubicin—testicular cancer	0.000114	0.000303	CcSEcCtD
Zopiclone—Vomiting—Doxorubicin—testicular cancer	0.000113	0.0003	CcSEcCtD
Zopiclone—Rash—Doxorubicin—testicular cancer	0.000112	0.000298	CcSEcCtD
Zopiclone—Dermatitis—Doxorubicin—testicular cancer	0.000112	0.000298	CcSEcCtD
Zopiclone—Headache—Doxorubicin—testicular cancer	0.000111	0.000296	CcSEcCtD
Zopiclone—Nausea—Doxorubicin—testicular cancer	0.000106	0.000281	CcSEcCtD
